Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.18 USD | +0.46% | +0.46% | -42.56% |
05-02 | Acurx Pharmaceuticals, Inc. Announces Presentation of Ibezapolstat Phase 2 Clinical Trial Results at ESCMID Global Scientific Conference | CI |
04-04 | Top Premarket Gainers | MT |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Equities
- ACXP Stock
- Revisions Acurx Pharmaceuticals, Inc.